Wealthcare Capital Management’s Integra LifeSciences IART Stock Holding History

Wealthcare Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-171	Closed	-$5K	–	316
2015 Q2	$5K	Sell	171 -2,801	-94%	-$74.6K	﹤0.01%	261
2015 Q1	$75K	Buy	+2,972	New	+$70.3K	0.01%	184

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wealthcare Capital Management's IART Position: Q3 2015 in Review

Wealthcare Capital Management sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 171 shares — an estimated $5K sold.

Wealthcare Capital Management first reported a position in IART in Q1 2015 and held it in 2 quarters. The position peaked at $75K in Q1 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

Wealthcare Capital Management reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
Wealthcare Capital Management sold 171 Integra LifeSciences shares in Q3 2015, an estimated $5K.
Wealthcare Capital Management first reported a position in Integra LifeSciences in Q1 2015 and held it in 2 quarters.
Wealthcare Capital Management's Integra LifeSciences position peaked at $75K in Q1 2015.
189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on Wealthcare Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.